Cost-utility and budget impact analysis of adding-on apremilast to biologic therapy in the treatment of moderate to severe plaque psoriasis, an Iranian payer perspective

Cost-utility and budget impact analysis of adding-on apremilast to biologic therapy in the treatment of moderate to severe plaque psoriasis, an Iranian payer perspective

Background and purpose: Plaque psoriasis is a chronic inflammatory disease with skin manifestations that affect the patients’ quality of life negatively. The prevalence of psoriasis is approximately 2-3% worldwide and appears to be still on the increase. Due to the stigma problems, psoriasis has a s...

Full description

Bibliographic Details
Main Authors: Marzieh Zargaran, Fatemeh Soleymani, Saman Ahmad Nasrollahi, Meysam Seyedifar, Mohammad Mehdi Ashrafian Rahaghi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Research in Pharmaceutical Sciences
Subjects:
budget impact; cost-utility; payer perspective; plaque psoriasis.
Online Access:http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2021;volume=16;issue=4;spage=381;epage=390;aulast=Zargaran

Similar Items

Similar Items